900
Views
10
CrossRef citations to date
0
Altmetric
Research Paper

Sequence and immunogenicity of a clinically approved novel measles virus vaccine vector

, , , , , , , , & show all
Pages 607-613 | Received 20 Oct 2012, Accepted 03 Nov 2012, Published online: 16 Jan 2013

References

  • Johnston MI, Fauci AS. An HIV vaccine--challenges and prospects. N Engl J Med 2008; 359:888 - 90; http://dx.doi.org/10.1056/NEJMp0806162; PMID: 18753644
  • Sekaly RP. The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?. J Exp Med 2008; 205:7 - 12; http://dx.doi.org/10.1084/jem.20072681; PMID: 18195078
  • Langhorne J, Ndungu FM, Sponaas AM, Marsh K. Immunity to malaria: more questions than answers. Nat Immunol 2008; 9:725 - 32; http://dx.doi.org/10.1038/ni.f.205; PMID: 18563083
  • Reyes-Sandoval A, Harty JT, Todryk SM. Viral vector vaccines make memory T cells against malaria. Immunology 2007; 121:158 - 65; http://dx.doi.org/10.1111/j.1365-2567.2006.02552.x; PMID: 17462077
  • Havenga M, Vogels R, Zuijdgeest D, Radosevic K, Mueller S, Sieuwerts M, et al. Novel replication-incompetent adenoviral B-group vectors: high vector stability and yield in PER.C6 cells. J Gen Virol 2006; 87:2135 - 43; http://dx.doi.org/10.1099/vir.0.81956-0; PMID: 16847108
  • Ly LH, McMurray DN. Tuberculosis: vaccines in the pipeline. Expert Rev Vaccines 2008; 7:635 - 50; http://dx.doi.org/10.1586/14760584.7.5.635; PMID: 18564018
  • Liniger M, Zuniga A, Naim HY. Use of viral vectors for the development of vaccines. Expert Rev Vaccines 2007; 6:255 - 66; http://dx.doi.org/10.1586/14760584.6.2.255; PMID: 17408374
  • Liniger M, Zuniga A, Tamin A, Azzouz-Morin TN, Knuchel M, Marty RR, et al. Induction of neutralising antibodies and cellular immune responses against SARS coronavirus by recombinant measles viruses. Vaccine 2008; 26:2164 - 74; PMID: 18346823
  • del Valle JR, Devaux P, Hodge G, Wegner NJ, McChesney MB, Cattaneo R. A vectored measles virus induces hepatitis B surface antigen antibodies while protecting macaques against measles virus challenge. J Virol 2007; 81:10597 - 605; http://dx.doi.org/10.1128/JVI.00923-07; PMID: 17634218
  • Schnell MJ. Viral vectors as potential HIV-1 vaccines. FEMS Microbiol Lett 2001; 200:123 - 9; http://dx.doi.org/10.1111/j.1574-6968.2001.tb10703.x; PMID: 11425463
  • Tangy F, Naim HY. Live attenuated measles vaccine as a potential multivalent pediatric vaccination vector. Viral Immunol 2005; 18:317 - 26; http://dx.doi.org/10.1089/vim.2005.18.317; PMID: 16035943
  • Lorin C, Mollet L, Delebecque F, Combredet C, Hurtrel B, Charneau P, et al. A single injection of recombinant measles virus vaccines expressing human immunodeficiency virus (HIV) type 1 clade B envelope glycoproteins induces neutralizing antibodies and cellular immune responses to HIV. J Virol 2004; 78:146 - 57; http://dx.doi.org/10.1128/JVI.78.1.146-157.2004; PMID: 14671096
  • Billeter MA, Naim HY, Udem SA. Reverse genetics of measles virus and resulting multivalent recombinant vaccines: applications of recombinant measles viruses. Curr Top Microbiol Immunol 2009; 329:129 - 62; http://dx.doi.org/10.1007/978-3-540-70523-9_7; PMID: 19198565
  • Radecke F, Spielhofer P, Schneider H, Kaelin K, Huber M, Dötsch C, et al. Rescue of measles viruses from cloned DNA. EMBO J 1995; 14:5773 - 84; PMID: 8846771
  • Desprès P, Combredet C, Frenkiel MP, Lorin C, Brahic M, Tangy F. Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis. J Infect Dis 2005; 191:207 - 14; http://dx.doi.org/10.1086/426824; PMID: 15609230
  • Liniger M, Zuniga A, Morin TN, Combardiere B, Marty R, Wiegand M, et al. Recombinant measles viruses expressing single or multiple antigens of human immunodeficiency virus (HIV-1) induce cellular and humoral immune responses. Vaccine 2009; 27:3299 - 305; http://dx.doi.org/10.1016/j.vaccine.2009.01.057; PMID: 19200842
  • Singh M, Billeter MA. A recombinant measles virus expressing biologically active human interleukin-12. J Gen Virol 1999; 80:101 - 6; PMID: 9934691
  • Singh M, Cattaneo R, Billeter MA. A recombinant measles virus expressing hepatitis B virus surface antigen induces humoral immune responses in genetically modified mice. J Virol 1999; 73:4823 - 8; PMID: 10233943
  • Guerbois M, Moris A, Combredet C, Najburg V, Ruffié C, Février M, et al. Live attenuated measles vaccine expressing HIV-1 Gag virus like particles covered with gp160DeltaV1V2 is strongly immunogenic. Virology 2009; 388:191 - 203; http://dx.doi.org/10.1016/j.virol.2009.02.047; PMID: 19345390
  • Wang Z, Hangartner L, Cornu TI, Martin LR, Zuniga A, Billeter MA, et al. Recombinant measles viruses expressing heterologous antigens of mumps and simian immunodeficiency viruses. Vaccine 2001; 19:2329 - 36; http://dx.doi.org/10.1016/S0264-410X(00)00523-5; PMID: 11257357
  • Zuniga A, Wang Z, Liniger M, Hangartner L, Caballero M, Pavlovic J, et al. Attenuated measles virus as a vaccine vector. Vaccine 2007; 25:2974 - 83; http://dx.doi.org/10.1016/j.vaccine.2007.01.064; PMID: 17303293
  • Dilraj A, Cutts FT, de Castro JF, Wheeler JG, Brown D, Roth C, et al. Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial. Lancet 2000; 355:798 - 803; http://dx.doi.org/10.1016/S0140-6736(99)95140-1; PMID: 10711928
  • Dilraj A, Sukhoo R, Cutts FT, Bennett JV. Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination. Vaccine 2007; 25:4170 - 4; http://dx.doi.org/10.1016/j.vaccine.2007.03.003; PMID: 17408818
  • Bennett JV, Fernandez de Castro J, Valdespino-Gomez JL, Garcia-Garcia MdeL, Islas-Romero R, Echaniz-Aviles G, et al. Aerosolized measles and measles-rubella vaccines induce better measles antibody booster responses than injected vaccines: randomized trials in Mexican schoolchildren. Bull World Health Organ 2002; 80:806 - 12; PMID: 12471401
  • Cutts FT, Clements CJ, Bennett JV. Alternative routes of measles immunization: a review. Biologicals 1997; 25:323 - 38; http://dx.doi.org/10.1006/biol.1997.0103; PMID: 9325001
  • Albrecht P, Herrmann K, Burns GR. Role of virus strain in conventional and enhanced measles plaque neutralization test. J Virol Methods 1981; 3:251 - 60; http://dx.doi.org/10.1016/0166-0934(81)90062-8; PMID: 7334066
  • Spielhofer P, Bächi T, Fehr T, Christiansen G, Cattaneo R, Kaelin K, et al. Chimeric measles viruses with a foreign envelope. J Virol 1998; 72:2150 - 9; PMID: 9499071
  • Verhaagh S, de Jong E, Goudsmit J, Lecollinet S, Gillissen G, de Vries M, et al. Human CD46-transgenic mice in studies involving replication-incompetent adenoviral type 35 vectors. J Gen Virol 2006; 87:255 - 65; http://dx.doi.org/10.1099/vir.0.81293-0; PMID: 16432010
  • Yannoutsos N, Ijzermans JN, Harkes C, Bonthuis F, Zhou CY, White D, et al. A membrane cofactor protein transgenic mouse model for the study of discordant xenograft rejection. Genes Cells 1996; 1:409 - 19; http://dx.doi.org/10.1046/j.1365-2443.1996.d01-244.x; PMID: 9135084
  • Baricević M, Forcić D, Gulija TK, Jug R, Mazuran R. Determination of the coding and non-coding nucleotide sequences of genuine Edmonston-Zagreb master seed and current working seed lot. Vaccine 2005; 23:1072 - 8; http://dx.doi.org/10.1016/j.vaccine.2004.08.021; PMID: 15620481
  • Parks CL, Lerch RA, Walpita P, Wang HP, Sidhu MS, Udem SA. Analysis of the noncoding regions of measles virus strains in the Edmonston vaccine lineage. J Virol 2001; 75:921 - 33; http://dx.doi.org/10.1128/JVI.75.2.921-933.2001; PMID: 11134305
  • Johansson EL, Wassén L, Holmgren J, Jertborn M, Rudin A. Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans. Infect Immun 2001; 69:7481 - 6; http://dx.doi.org/10.1128/IAI.69.12.7481-7486.2001; PMID: 11705923
  • Kozlowski PA, Cu-Uvin S, Neutra MR, Flanigan TP. Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women. Infect Immun 1997; 65:1387 - 94; PMID: 9119478
  • Nardelli-Haefliger D, Wirthner D, Schiller JT, Lowy DR, Hildesheim A, Ponci F, et al. Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles. J Natl Cancer Inst 2003; 95:1128 - 37; http://dx.doi.org/10.1093/jnci/djg018; PMID: 12902442
  • Mrkic B, Pavlovic J, Rülicke T, Volpe P, Buchholz CJ, Hourcade D, et al. Measles virus spread and pathogenesis in genetically modified mice. J Virol 1998; 72:7420 - 7; PMID: 9696838

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.